Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: opalapril who wrote (9621)	4/13/1999 7:51:00 PM
From: ballydog1	Respond to of 17367

Submitted for your approval from the "Twilight Zone" : Seemingly a promising young biotech company, perennially on the verge of final FDA approval for a life-saving drug, only to re-emerge as a partner in an internet biotech bookstore/portal/netbank/e-commerce company, with the new moniker of Xoma.com Of course the announcement of this alliance will drive the shares up to unheard of heights, as CNBC will interview management (Murphy & McCamant will put in a cameo appearance) , and the shareholder's will finally have their day in the sun. As an afterthought the FDA will finally grant approval for BPI, realizing that to resist the inevitable would be the ultimate in futility. The shares will promptly sell off on the news of the approval, since Xoma might be diluting its virtual internet earnings glory to work solely in the biotech sphere of saving lives, and generating actual income. forcing a real P/E on the shares, something no self-respecting internet analyst could stand !